← Back to Analyst Consensus 
LRMR Buy
Larimar Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 17
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 5, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Jun 30, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| May 27, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| May 18, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Mar 20, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Mar 3, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Feb 25, 2026 | Citigroup | maintain | Buy → Buy | $14 | 54% |
| Feb 25, 2026 | Wedbush | reiterate | Outperform → Outperform | $11 | 58% |
| Oct 2, 2025 | Oppenheimer | maintain | Outperform → Outperform | $21 | 52% |
| Sep 30, 2025 | Wedbush | maintain | Outperform → Outperform | $11 | 58% |
| Sep 30, 2025 | Baird | maintain | Outperform → Outperform | $7 | 55% |
| Aug 19, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $18 | 53% |
| Aug 15, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $18 | 53% |
| Jun 25, 2025 | Guggenheim | reiterate | Buy → Buy | $26 | 52% |
| Jun 24, 2025 | Wedbush | maintain | Outperform → Outperform | $15 | 58% |
| Jun 24, 2025 | Guggenheim | reiterate | Buy → Buy | $26 | 52% |
| Mar 25, 2025 | Guggenheim | reiterate | Buy → Buy | $26 | 52% |
| Mar 25, 2025 | Baird | maintain | Outperform → Outperform | $10 | 55% |
| Mar 25, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| Jan 29, 2025 | Truist Securities | initiate | — → Buy | $18 | 54% |
| Jan 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Dec 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Dec 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Nov 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Oct 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Oct 16, 2024 | Oppenheimer | initiate | — → Outperform | $26 | 52% |
| Oct 3, 2024 | Wedbush | initiate | — → Outperform | $22 | 58% |
| Oct 2, 2024 | HC Wainwright & Co. | initiate | — → Buy | $15 | 44% |
| Sep 12, 2024 | Jones Trading | initiate | — → Buy | $14 | 50% |
| Sep 4, 2024 | Baird | initiate | — → Outperform | $16 | 55% |
| May 31, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $25 | 53% |
| May 22, 2024 | Citigroup | maintain | Buy → Buy | $14 | 54% |
| May 21, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $25 | 53% |
| Apr 3, 2024 | Leerink Partners | initiate | — → Outperform | $25 | 51% |
| Mar 15, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $25 | 53% |
| Mar 12, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $25 | 53% |
| Feb 13, 2024 | Citigroup | maintain | Buy → Buy | $10 | 54% |
| Feb 13, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $25 | 53% |
| Nov 17, 2023 | Citigroup | upgrade | Neutral → Buy | $4.5 | 54% |
| Aug 15, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $17 | 53% |
| May 18, 2023 | Citigroup | maintain | Neutral → Neutral | $4.5 | 54% |
| May 17, 2023 | Guggenheim | maintain | Buy → Buy | $14 | 52% |
| May 16, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $15 | 53% |
| May 15, 2023 | Citigroup | maintain | Neutral → Neutral | $7 | 54% |
| Mar 15, 2023 | Guggenheim | reiterate | — → Buy | $12 | 52% |
| Mar 14, 2023 | JMP Securities | maintain | Market Outperform → Market Outperform | $15 | 53% |
| Mar 1, 2023 | JMP Securities | maintain | Market Outperform → Market Outperform | $15 | 53% |
| Jan 24, 2023 | JMP Securities | maintain | Market Outperform → Market Outperform | $16 | 53% |
| Dec 13, 2022 | Citigroup | initiate | — → Neutral | $4 | 54% |
| Oct 19, 2022 | Guggenheim | initiate | — → Buy | $12 | 52% |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days